x
Filter:
Filters applied
- Melanoma
- Review ArticleRemove Review Article filter
- SCCRemove SCC filter
Keyword
- squamous cell carcinoma2
- ABC1
- aldehyde dehydrogenase1
- ALDH1
- ataxia telangiectasia mutated1
- ATM1
- ATP binding cassette1
- cancer stem cell1
- CSC1
- DDR1
- DNA-damage response1
- K151
- keratin 151
- mammalian target of rapamycin1
- MAPK1
- matrix metalloproteinase1
- mitogen-activated protein kinase1
- MMP1
- mTOR1
- PKD11
- protein kinase D11
- SASP1
- SC1
- SP1
Melanoma
2 Results
- ReviewOpen Archive
Cancer Stem Cells in Squamous Cell Carcinoma
Journal of Investigative DermatologyVol. 137Issue 1p31–37Published online: September 16, 2016- Zhe Jian
- Alexander Strait
- Antonio Jimeno
- Xiao-Jing Wang
Cited in Scopus: 21Cancer stem cells (CSCs) are found in many cancer types, including squamous cell carcinoma (SCC). CSCs initiate cancer formation and are linked to metastasis and resistance to therapies. Studies have revealed that several distinct CSC populations coexist in SCC and that tumor initiation and metastatic potential of these populations can be uncoupled. Therefore, it is critical to understand CSC biology to develop novel CSC-targeted therapies for patients with SCC with poor prognoses. This review compares the properties of CSCs in SCC with normal stem cells in the skin, summarizes current advances and characteristics of CSCs, and considers the challenges for CSC-targeted treatment of SCC. - ReviewOpen Archive
The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging
Journal of Investigative DermatologyVol. 136Issue 11p2133–2139Published online: August 18, 2016- Kanad Ghosh
- Brian C. Capell
Cited in Scopus: 88Cellular senescence, a state of stable cell cycle arrest in response to cellular stress, is an indispensable mechanism to counter tumorigenesis by halting the proliferation of damaged cells. However, through the secretion of an array of diverse cytokines, chemokines, growth factors, and proteases known as the senescence-associated secretory phenotype (SASP), senescent cells can paradoxically promote carcinogenesis. Consistent with this, removal of senescent cells delays the onset of cancer and prolongs lifespan in vivo, potentially in part through SASP reduction.